Molecular imaging in Parkinson's Disease / / Cristina Polito.

The present work explores brain functional changes in drug-naïve Parkinson's disease (PD) patients by means of molecular imaging techniques. Thirty-one consecutive drug-naïve PD patients from the Neurological Clinic of the University of Florence underwent clinical assessment, neuropsychological...

Full description

Saved in:
Bibliographic Details
Superior document:Premio Firenze University Press tesi di dottorato (Series), ; 18
VerfasserIn:
Place / Publishing House:Firenze : : Firenze University Press,, 2011
Year of Publication:2011
Language:Italian
Series:Premio Firenze University Press tesi di dottorato (Series) ; 18.
Physical Description:1 online resource (68 pages) :; illustrations; digital, PDF file(s).
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The present work explores brain functional changes in drug-naïve Parkinson's disease (PD) patients by means of molecular imaging techniques. Thirty-one consecutive drug-naïve PD patients from the Neurological Clinic of the University of Florence underwent clinical assessment, neuropsychological assessment, MRI, [123I]FP-CIT SPECT, [18F]FDG PET. First, [18F]FDG-PET was employed to identify in drug-naïve PD patients brain metabolic alteration uniquely related to disease process and not modulated by anti-parkinsonian therapeutic intervention. Second, [18F]FDG-PET and [123I]FP-CIT SPECT were employed together to explore the early functional changes in brain function related to dopaminergic depletion in the putamen and in the caudate nucleus.
Bibliography:Includes bibliographical references.
Access:Open Access
Hierarchical level:Monograph
Statement of Responsibility: Cristina Polito.